An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland
Prostatitis
About this trial
This is an interventional treatment trial for Prostatitis focused on measuring prostatitis, Elmiron, pentosan polysulfate sodium
Eligibility Criteria
Inclusion Criteria: Diagnosis of chronic non-bacterial prostatitis/chronic pelvic pain syndrome symptoms of discomfort or pain in the perineal and/or pelvic region (lower abdomen) for at least three of the last six months for which there is no recognized cause symptoms persist despite treatment with antibiotics for non-bacterial prostatitis in the past six months. Exclusion Criteria: Clinically significant medical problems or other organ abnormalities psychiatric disorders urinary tract infection during the last three months history of bladder, urethral or prostate cancer Prostate Specific Antigen (PSA) greater than or equal to 4 ng/mL diagnosis or treatment for genital herpes or herpes flare within the last year.
Sites / Locations
Arms of the Study
Arm 1
Experimental
001
pentosan polysulfate sodium